Predominant infiltration of macrophages and CD8+T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer-Reference-Cited by-同舟云学术

Predominant infiltration of macrophages and CD8+T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer

Published:2008-09-15 Issue:6 Volume:113 Page:1387-1395
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Kawai Osamu,Ishii Genichiro,Kubota Kaoru,Murata Yukinori,Naito Yoichi,Mizuno Tetsuya,Aokage Keiju,Saijo Nagahiro,Nishiwaki Yutaka,Gemma Akihiko,Kudoh Syoji,Ochiai Atsushi

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference43 articles.

1. Chemotherapy in nonsmall cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized clinical trials;Nonsmall Cell Lung Cancer Collaborative Group;BMJ,1995

2. New combinations in the treatment of lung cancer: a time for optimism;Bunn;Chest,2000

3. Chemotherapy for advanced nonsmall-cell lung cancer: who, what, when, why?;Bunn;J Clin Oncol,2002

4. Overall long-term survival in lung cancer analyzed in 610 unselected patients [in Spanish];Sanchez de Cos Escuin;Arch Bronconeumol,2004

5. CD8+ tumor-infiltrating lymphocytes together with CD4+ tumor-infiltrating lymphocytes and dendritic cells improve the prognosis of patients with pancreatic adenocarcinoma;Fukunaga;Pancreas,2004

Cited by 338 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The prognostic effect of infiltrating immune cells is shaped by proximal M2 macrophages in lung adenocarcinoma;Molecular Cancer;2024-09-04

2. A Case of Spontaneous Regression of Lung Cancer After Biopsy;Haigan;2024-08-20

3. The Role of Platelet to Lymphocyte Ratio (PLR) in Predicting Early Treatment Response in Diffuse Large B Cell Lymphoma;Indian Journal of Hematology and Blood Transfusion;2024-08-12

4. Reduced EO771-induced tumour growth and increased overall-survival of mice ablated for immune cell-specific catalytic subunit Cβ2 of protein kinase A;Immunology Letters;2024-08

5. Efficacy and safety of immune checkpoint inhibitors in solid tumor patients combined with chronic coronary syndromes or its risk factor: a nationwide multicenter cohort study;Cancer Immunology, Immunotherapy;2024-06-08